Vermillion (VRML) Shares on the Move as Co. Gets Patent for Platelet Biomarkers for Cancer
Go back to Vermillion (VRML) Shares on the Move as Co. Gets Patent for Platelet Biomarkers for Cancer| Vermillion, Inc. (NASDAQ: VRML) | Delayed: 4.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.00 | 52 Week High | $2.00 | |||
| Open | $43.04 | 52 Week Low | $0.76 | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $-0.47 | |||
| Volume | 600 | |||||
